Exploring the structure and function of the P-glycoprotein multidrug transporter using fluorescence spectroscopic tools.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Seminars in Cell and Developmental Biology

• Publication date

  2001-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/SCDB.2000.0251PMID 11428918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site.

  2001cited by this paper
• Drug transport by reconstituted P-glycoprotein in proteoliposomes. Effect of substrates and modulators, and dependence on bilayer phase state.

  2001cited by this paper
• FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated.

  2001cited by this paper
• Can multidrug resistance mechanisms be modified?

  2000cited by this paper
• Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides.

  2000cited by this paper
• Analysis of the properties of the N-terminal nucleotide-binding domain of human P-glycoprotein.

  2000cited by this paper
• ABC transporters in lipid transport.

  2000cited by this paper
• A structure-based mechanism for drug binding by multidrug transporters.

  2000cited by this paper
• Simple purification of highly active biotinylated P-glycoprotein: enantiomer-specific modulation of drug-stimulated ATPase activity.

  2000cited by this paper
• Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily.

  2000cited by this paper
• Recognition of multiple drugs by a single protein: a trivial solution of an old paradox.

  2000cited by this paper
• Functional Characterization of Glycosylation-Deficient Human P-Glycoprotein Using A Vaccinia Virus Expression System

  2000cited by this paper
• MDR3 P-glycoprotein, a Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs and Directly Interacts with Drugs as Judged by Interference with Nucleotide Trapping*

  2000cited by this paper
• ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans.

  1999cited by this paper
• Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

  1999cited by this paper
• The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.

  1999cited by this paper
• P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs.

  1999cited by this paper
• P-Glycoprotein, a gatekeeper in the blood-brain barrier.

  1999cited by this paper
• Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies.

  1999cited by this paper
• Subunit interactions in ABC transporters: towards a functional architecture.

  1999cited by this paper
• ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans.

  1999cited by this paper
• Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.

  1998cited by this paper
• Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.

  1998cited by this paper
• Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: a resonance energy transfer study.

  1998cited by this paper
• Spectroscopic and biophysical approaches for studying the structure and function of the P-glycoprotein multidrug transporter.

  1998cited by this paper
• Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein.

  1998cited by this paper
• The ATPase and ATP-binding functions of P-glycoprotein--modulation by interaction with defined phospholipids.

  1998cited by this paper
• High-level expression of mouse Mdr3 P-glycoprotein in yeast Pichia pastoris and characterization of ATPase activity.

  1998cited by this paper
• ATP-binding-cassette (ABC) transport systems: functional and structural aspects of the ATP-hydrolyzing subunits/domains.

  1998cited by this paper
• Crystal structure of the ATP-binding subunit of an ABC transporter

  1998cited by this paper
• ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR.

  1997cited by this paper
• Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.

  1997cited by this paper
• Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein.

  1997cited by this paper
• Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter.

  1997cited by this paper
• P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer.

  1997cited by this paper
• Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.

  1997cited by this paper
• The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?

  1997cited by this paper
• Recombinant N-terminal Nucleotide-binding Domain from Mouse P-glycoprotein

  1996cited by this paper
• Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.

  1996cited by this paper
• Transmembrane Organization of Mouse P-glycoprotein Determined by Epitope Insertion and Immunofluorescence (*)

  1996cited by this paper
• Efficient Purification and Reconstitution of P-glycoprotein for Functional and Structural Studies*

  1996cited by this paper
• P-glycoprotein--a mediator of multidrug resistance in tumour cells.

  1996cited by this paper
• Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport.

  1996cited by this paper
• P-glycoprotein multidrug resistance and cancer.

  1996cited by this paper
• Functional Reconstitution of P-glycoprotein Reveals an Apparent Near Stoichiometric Drug Transport to ATP Hydrolysis (*)

  1996cited by this paper
• Reconstitution of Drug Transport by Purified P-glycoprotein (*)

  1995cited by this paper
• Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.

  1995cited by this paper
• Phosphatidylcholine translocase: a physiological role for the mdr2 gene.

  1994cited by this paper
• Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein.

  1994cited by this paper
• Transmembrane aromatic amino acid distribution in P-glycoprotein. A functional role in broad substrate specificity.

  1994cited by this paper
• Overexpression and purification of the carboxyl-terminal nucleotide-binding domain from mouse P-glycoprotein. Strategic location of a tryptophan residue.

  1994cited by this paper
• The effects of lipids and detergents on ATPase-active P-glycoprotein.

  1993cited by this paper
• Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein.

  1993cited by this paper
• Is the multidrug transporter a flippase?

  1992cited by this paper
• Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells.

  1992cited by this paper

• Transcriptomic profiling reveals prognostic gene signatures and immune landscape alterations in canine diffuse large B-cell lymphoma

  2026cites this paper
• Exploring the potential of P-glycoprotein inhibitors in the targeted delivery of anti-cancer drugs: A comprehensive review.

  2024cites this paper
• Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer

  2024cites this paper
• P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

  2023cites this paper
• Non-ionic Surfactants as a P-Glycoprotein(P-gp) Efflux Inhibitor for Optimal Drug Delivery—A Concise Outlook

  2022cites this paper
• Patent survey on chemosensitizers (2015–2019)

  2021cites this paper
• Diminished Expression of P-glycoprotein Using Focused Ultrasound Is Associated With JNK-Dependent Signaling Pathway in Cerebral Blood Vessels

  2019cites this paper
• ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?

  2018cites this paper
• Conformational changes in a multidrug resistance ABC transporter DrrAB: Fluorescence-based approaches to study substrate binding.

  2018influential citation
• Substrate Binding and Energy Transduction in a Multidrug Resistance ABC Transporter DrrAB

  2018cites this paper
• UvA-DARE ( Digital Academic Repository ) ABC transporters in Arthropods : genomic comparison and role in insecticide transport and resistance

  2017cites this paper
• PLASMA GLYCOPROTEIN INHIBITORS AS A NEW TARGET FOR OPTIMAL DRUG DELIVERY

  2015cites this paper
• Reversing cancer multidrug resistance: insights into the efflux by ABC transports from in silico studies

  2015cites this paper
• Interaction of the P-Glycoprotein Multidrug Transporter with Sterols.

  2015cites this paper
• Therapeutic potential of nanocarrier for overcoming to P-glycoprotein

  2014cites this paper
• The ABC gene family in arthropods: comparative genomics and role in insecticide transport and resistance.

  2014cites this paper
• Reversible dimers of the atypical antipsychotic quetiapine inhibit p-glycoprotein-mediated efflux in vitro with increased binding affinity and in situ at the blood-brain barrier.

  2014cites this paper
• Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function

  2014cites this paper
• Multidrug Resistance Protein

  2014cites this paper
• Quantitative fluorescence microscopy provides high resolution imaging of passive diffusion and P-gp mediated efflux at the in vivo blood-brain barrier.

  2013cites this paper
• P-glycoprotein Inhibition for Optimal Drug Delivery

  2013cites this paper
• Lipid bilayer properties control membrane partitioning, binding, and transport of p-glycoprotein substrates.

  2013cites this paper
• Characterizing drug interactions in the substrate binding pocket of the P-glycoprotein multidrug efflux pump

  2012cites this paper
• [Important toxic and undesirable effects of medicaments in animals from the pharmacists viewpoint].

  2012cites this paper
• Development and application of novel analytical methods for molecularly targeted cancer therapeutics

  2011cites this paper
• Pancreatic cancer is highly resistant to chemotherapy drugs

  2011cites this paper
• Overcoming drug resistance in pancreatic cancer

  2011cites this paper
• Catalytic and transport cycles of ABC exporters.

  2011cites this paper
• Fluorescence studies of drug binding and translocation by membrane transporters.

  2010cites this paper
• P-glycoprotein ATPase from the resistant pest, Helicoverpa armigera: purification, characterization and effect of various insecticides on its transport function.

  2010cites this paper
• ABC efflux pump-based resistance to chemotherapy drugs.

  2009cites this paper
• Multidrug Resistance Protein ( P-Glycoprotein ; MDR 1 )

  2009influential citation
• Role of membrane transporters in the safety profile of drugs

  2009cites this paper
• In vitro chemosensitivity testing of primary and recurrent breast carcinomas and its clinical significance

  2008cites this paper
• Benzodiazepine-Mediated Structural Changes in the Multidrug Transporter P-Glycoprotein: An Intrinsic Fluorescence Quenching Analysis

  2008cites this paper
• Role of TMS5: staphylococcal multidrug-efflux protein QacA.

  2008cites this paper
• ABC multidrug transporters: structure, function and role in chemoresistance.

  2008cites this paper
• In vitro chemosensitivity testing of primary and recurrent breast carcinomas and its clinical significance

  2008cites this paper
• Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.

  2008cites this paper
• Overlapping ligand specificity of P-glycoprotein and serum alpha(1)-acid glycoprotein: evidences and potential implications.

  2007cites this paper
• Interaction of insecticides with mammalian P-glycoprotein and their effect on its transport function.

  2007cites this paper
• Sensitivity of P-glycoprotein tryptophan residues to benzodiazepines and ATP interaction.

  2007cites this paper
• Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporter.

  2006cites this paper
• Defense System Transporters: Participation in a Chemoimmunity Human Multidrug Resistance ABCB and ABCG

  2006cites this paper
• Characterisation of the Doxorubicin pump of Streptomyces peucetius : the DrrA component of the DrrAB ATP-binding cassette transporter.

  2006cites this paper
• Multidrug Resistance Protein: P‐Glycoprotein

  2006cites this paper
• Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system.

  2006cites this paper
• Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).

  2006cites this paper
• The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells.

  2005influential citation
• Isolated Rafts from Adriamycin-Resistant P388 Cells Contain Functional ATPases and Provide an Easy Test System for P-glycoprotein–Related Activities

  2005cites this paper
• New Insights into the Drug Binding, Transport and Lipid Flippase Activities of the P-Glycoprotein Multidrug Transporter

  2005cites this paper
• Interaction of LDS-751 with P-glycoprotein and mapping of the location of the R drug binding site.

  2005cites this paper
• Role of Proteinase-Activated Receptors in Brain Function

  2005cites this paper
• ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal

  2005cites this paper
• ABC Transporter Proteins and Cellular Drug Resistance

  2004cites this paper
• Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine.

  2004cites this paper
• Effect of Pluronic P85 on ATPase Activity of Drug Efflux Transporters

  2004cites this paper
• The structure and function of drug pumps: an update.

  2003cites this paper
• Reconstitution of membrane transporters.

  2003cites this paper
• Fluorescence Techniques for Studying Membrane Transport Proteins

  2003cites this paper
• Functional analysis of genetic mutations in nucleotide binding domain 2 of the human retina specific ABC transporter.

  2003cites this paper
• Developmental aspects of blood-brain barrier (BBB) and rat brain endothelial (RBE4) cells as in vitro model for studies on chlorpyrifos transport.

  2003cites this paper
• Transition state P-glycoprotein binds drugs and modulators with unchanged affinity, suggesting a concerted transport mechanism.

  2003cites this paper
• Structure and function of efflux pumps that confer resistance to drugs.

  2003cites this paper
• Fluorescent Substrates of Sister-P-Glycoprotein (BSEP) Evaluated as Markers of Active Transport and Inhibition: Evidence for Contingent Unequal Binding Sites

  2003cites this paper
• Optical single transporter recording: transport kinetics in microarrays of membrane patches.

  2003cites this paper
• Single ion channel imaging.

  2003cites this paper
• Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells.

  2002cites this paper
• NMDA sensitization and stimulation by peroxynitrite, nitric oxide, and organic solvents as the mechanism of chemical sensitivity in multiple chemical sensitivity

  2002cites this paper
• Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet.

  2002cites this paper
• Why are bacteria refractory to antimicrobials?

  2002cites this paper
• Mammalian ABC transporters in health and disease.

  2002cites this paper
• P-glycoprotein-mediated efflux as a major factor in the variance of absorption and distribution of drugs: modulation of chemotherapy resistance.

  2002cites this paper
• Multidrug resistance and cancer: the role of the human ABC transporter ABCG2.

  2002cites this paper
• Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.

  2001cites this paper
• Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein

  2001cites this paper